Zydus Lifesciences Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Mar' 24	Dec' 23	Sep' 23	Jun' 23	Mar' 23

Sales

3,332.40

2,371.30

2,159.30

2,955.70

2,579.30

Operating profit

1,569.20

699.10

649.40

1,141.00

772.50

Interest

106.20

103.90

90.90

89.70

85.00

Gross profit

1,824.10

702.00

1,093.00

1,133.70

938.70

EPS (Rs)

13.97

4.45

7.95

7.72

4.85

Other income

361.10

106.80

534.50

82.40

251.20

Stock adjustment

-86.20

24.50

-98.10

28.10

-14.70

Raw material

737.20

681.60

705.90

876.70

806.70

Power and fuel

-

-

-

-

-

Employee expenses

405.10

373.00

377.70

351.70

353.10

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

707.10

593.10

524.40

558.20

661.70

Provisions made

-

-

-

-

-

Depreciation

130.60

127.70

124.90

121.20

119.90

Taxation

279.70

123.90

163.10

231.60

124.30

Net profit / loss

1,405.20

450.40

805.00

780.90

490.70

Extra ordinary item

-8.60

-

-

-

-203.80

Prior year adjustments

-

-

-

-

-

Equity capital

100.60

101.20

101.20

101.20

101.20

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

47.09

29.48

30.07

38.60

29.95

GPM (%)

49.39

28.33

40.57

37.32

33.16

NPM (%)

38.05

18.18

29.88

25.70

17.34